A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This Phase 1 study will assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of ACT-1004-1239 in healthy subjects.
Epistemonikos ID: 0e738936bec339af6e9885047bfe7db50ae7f88d
First added on: May 22, 2024